Skip to content

Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure

Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure: Multicentral Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04445961
Acronym
COVID-VENT
Enrollment
117
Registered
2020-06-24
Start date
2020-05-01
Completion date
2020-08-14
Last updated
2020-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS Pneumonia

Keywords

SARS Pneumonia, ARDS, COVID-19, compliance, recruitability

Brief summary

Data on respiratory mechanics and gas exchange in acute respiratory failure in COVID-19 patients is limited. Knowledge of respiratory mechanics and gas exchange in COVID-19 can lead to different selection of mechanical ventilation strategy, reduce ventilator-associated lung injury and improve outcomes. The objective of the study is to evaluate the respiratory mechanics, lung recruitability and gas exchange in COVID-19 -associated acute respiratory failure during the whole course of mechanical ventilation - invasive or non-invasive.

Detailed description

In December 2019, an outbreak of a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China and rapidly spread worldwide. The World Health Organization (WHO) declared the outbreak a pandemic on March 11th, 2020. The clinical disease (COVID-19) results in critical illness in about 5% of patients with predominant acute respiratory failure. The goal of the study is the evaluation of the respiratory mechanics (peak inspiratory pressure (PIP), plateau pressure (Pplat), static compliance (Cstat), driving pressure (DP) at different positive end-expiratory pressure (PEEP) levels and different tidal volumes (Vt) (6-8 ml/kg ideal body weight), lung recruitability (by change of DP and oxygenation) and gas exchange (PaO2/FiO2 ratio and alveolar dead space) in COVID-19 -associated acute respiratory failure during the whole course of mechanical ventilation - invasive or non-invasive for selection of safe and effective PEEP level, Vt, respiratory rate (RR) and inspiratory oxygen fraction (FiO2) during the whole course of mechanical ventilation - invasive or non-invasive. This study is multicentral observational trial in 3 University clinics.

Interventions

DIAGNOSTIC_TESTRespiratory mechanics measurement

Measurement of peak inspiratory pressure, plateau pressure, calculation of static compliance and driving pressure

DIAGNOSTIC_TESTGas exchange measurement

Measurement of arterial oxygen and tension and arterial dioxide tension, calculation of arterial partial oxygen tension to inspiratory oxygen fraction (PaO2/FiO2) ratio and alveolar dead space

Sponsors

I.M. Sechenov First Moscow State Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* all patients with COVID-19 and acute respiratory failure on invasive and noninvasive ventilation

Exclusion criteria

* Patients who reached the following goals at conventional oxygen therapy (oxygen flow \< 15 l/min): peripheral capillary oxygen saturation(SpO2) \> 93%, no visible work of auxiliary respiratory muscles, no fatigue, stable hemodynamics (no need in any catecholamines and/or life-threatening heart rhythm abnormalities), * less than 24 ours in intensive care unit (ICU) by any reason, * lung emphysema, * primary lung diseases (chronic obstructive lung disease-COPD, interstitial lung diseases, etc) or tumour metastases in lungs, * chronic decompensated diseases with extrapulmonary organ dysfunction (tumour progression, liver cirrhosis, congestive heart failure), * atonic coma.

Design outcomes

Primary

MeasureTime frameDescription
Optimum positive end-expiratory pressure (PEEP) levelOn day 1 during mechanical ventilationPositive end-expiratory pressure (PEEP) selection at minimum level with maximum static compliance and the highest peripheral capillary oxygen saturation over fraction of inspired oxygen (SpO2/FiO2)
Number of patients with recruitable lungOn day 1 during mechanical ventilationPeripheral capillary oxygen saturation (SpO2) change from 90% after recruitment maneuver (doubled tidal volume for 15 respiratory cycles) - if peripheral capillary oxygen saturation (SpO2) after recruitment maneuver more than 95%-recruitable

Secondary

MeasureTime frameDescription
Change in arterial partial oxygen tension to inspiratory oxygen fraction (PaO2/FiO2) ratioOn day 1, 3, 5, 7, 10, 14, 21 during mechanical ventilationCalculation of the arterial partial oxygen tension to inspiratory oxygen fraction (PaO2/FiO2) ratio using arterial oxygen tension measurement
Change in alveolar dead spaceOn day 1, 3, 5, 7, 10, 14, 21 during mechanical ventilationCalculation of the alveolar dead space using end-tidal carbon dioxide measurement and arterial carbon dioxide tension measurement
Change in driving pressure with different positive end-expiratory pressure (PEEP) levelsOn day 1, 3, 5, 7, 10, 14, 21 during mechanical ventilationDriving pressure calculation at different positive end-expiratory pressure (PEEP) levels (8, 10, 12, 14)
Optimum positive end-expiratory pressure (PEEP) levelOn day 3, 5, 10, 14, 21 during mechanical ventilationPositive end-expiratory pressure (PEEP) selection at minimum level with maximum static compliance and the highest peripheral capillary oxygen saturation over fraction of inspired oxygen (SpO2/FiO2)
Change in plethysmogram variability during recruitment maneuverOn day 1, 3, 5, 7, 10, 14, 21 during mechanical ventilationMeasurement of plethysmogram variability before and during recruitment maneuver

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026